Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides
View: Text | PDF
Research Article Vascular biology

mTOR inhibition prevents angiotensin II–induced aortic rupture and pseudoaneurysm but promotes dissection in Apoe-deficient mice

  • Text
  • PDF
Abstract

Aortic dissection and rupture are triggered by decreased vascular wall strength and/or increased mechanical loads. We investigated the role of mTOR signaling in aortopathy using a well-described model of angiotensin II–induced dissection, aneurysm, or rupture of the suprarenal abdominal aorta in Apoe-deficient mice. Although not widely appreciated, nonlethal hemorrhagic lesions present as pseudoaneurysms without significant dissection in this model. Angiotensin II–induced aortic tears result in free rupture, contained rupture with subadventitial hematoma (forming pseudoaneurysms), dilatation, or healing, while the media invariably thickens regardless of mural tears. Medial thickening results from smooth muscle cell hypertrophy and extracellular matrix accumulation, including matricellular proteins. Angiotensin II activates mTOR signaling in vascular wall cells, and inhibition of mTOR signaling by rapamycin prevents aortic rupture but promotes dissection. Decreased aortic rupture correlates with decreased inflammation and metalloproteinase expression, whereas extensive dissection correlates with induction of matricellular proteins that modulate adhesion of vascular cells. Thus, mTOR activation in vascular wall cells determines whether aortic tears progress to dissection or rupture. Previous mechanistic studies of aortic aneurysm and dissection by angiotensin II in Apoe-deficient mice should be reinterpreted as clinically relevant to pseudoaneurysms, and mTOR inhibition for aortic disease should be explored with caution.

Authors

Changshun He, Bo Jiang, Mo Wang, Pengwei Ren, Sae-Il Murtada, Alexander W. Caulk, Guangxin Li, Lingfeng Qin, Roland Assi, Constantinos J. Lovoulos, Martin A. Schwartz, Jay D. Humphrey, George Tellides

×

Figure 5

mTOR inhibition prevents aortic rupture and pseudoaneurysm but promotes dissection.

Options: View larger image (or click on image) Download as PowerPoint
mTOR inhibition prevents aortic rupture and pseudoaneurysm but promotes ...
Apoe–/– mice were infused with AngII with or without rapamycin (Rapa) treatment for 7 days. (A) Western blot of aortas for phospho-S6 (p-S6) and S6. (B) Relative expression of phospho-S6 from pooled experiments (n = 8). (C) Confocal microscopy for phospho-S6 expression (white) and DAPI-labeled nuclei (blue) in media of suprarenal abdominal aortas, scale bar: 25 μm. (D) Incidence of aortic hematomas at 1–7 days. (E) Appearance of aortic hematomas (arrowheads), scale provided by needle of 1.27 mm outer diameter. (F) Survival of animals infused with AngII without (n = 42) or with (n = 40) rapamycin treatment for 7 days. (G) H&E stains showing medial thickening without hematomas compared with contained rupture (black arrowhead) and dissection (red arrowhead) in the absence or presence of rapamycin, respectively; scale bars: 200 μm (note different magnification of larger pseudoaneurysm). (H) Verhoeff-Van Gieson staining similarly shows thickened media without hematomas versus contained rupture (black arrowhead) and dissection (red arrowhead) in the absence or presence of rapamycin, respectively; TER-119 immunostain for erythrocytes in insets, scale bars: 50 μm. (I) Incidence of suprarenal abdominal aorta complications in AngII-infused Apoe–/– mice treated with rapamycin. (J) Incidence of aortic hematomas in AngII-infused mice treated with rapamycin from day 0 to 7 or from day –14 to 7. (K) Systolic blood pressure (BP) in Apoe–/– mice infused with saline (n = 11), AngII (n = 10), or AngII with rapamycin treatment (n = 11). Individual data shown for continuous variables, bars represent mean ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001, unpaired, 2-tailed t test (B), Fisher’s exact test (D and J), and 1‑way ANOVA with Tukey’s multiple-comparison test (K).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts